D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 66.79 CNY 5.26% Market Closed
Market Cap: 30.8B CNY

Wall Street
Price Targets

Price Targets Summary
Dizal Jiangsu Pharmaceutical Co Ltd

Wall Street analysts forecast Dizal Jiangsu Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dizal Jiangsu Pharmaceutical Co Ltd is 96.77 CNY with a low forecast of 90.9 CNY and a high forecast of 104.74 CNY.

Lowest
Price Target
90.9 CNY
36% Upside
Average
Price Target
96.77 CNY
45% Upside
Highest
Price Target
104.74 CNY
57% Upside
Dizal Jiangsu Pharmaceutical Co Ltd Competitors:
Price Targets
688331
RemeGen Co Ltd
3% Downside
IPH
Innate Pharma SA
228% Upside
TNG
Transgene SA
54% Upside
CGON
CG Oncology Inc
35% Upside
6855
Ascentage Pharma Group International
85% Upside
4BB
4Basebio PLC
194% Upside
CRVO
Diffusion Pharmaceuticals Inc
196% Upside
XNCR
Xencor Inc
107% Upside

Revenue
Forecast

Revenue Estimate
Dizal Jiangsu Pharmaceutical Co Ltd

For the last 5 years the compound annual growth rate for Dizal Jiangsu Pharmaceutical Co Ltd's revenue is 54%. The projected CAGR for the next 4 years is 107%.

54%
Past Growth
107%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Dizal Jiangsu Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Dizal Jiangsu Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dizal Jiangsu Pharmaceutical Co Ltd's stock price target?
Price Target
96.77 CNY

According to Wall Street analysts, the average 1-year price target for Dizal Jiangsu Pharmaceutical Co Ltd is 96.77 CNY with a low forecast of 90.9 CNY and a high forecast of 104.74 CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
107%

For the last 5 years the compound annual growth rate for Dizal Jiangsu Pharmaceutical Co Ltd's revenue is 54%. The projected CAGR for the next 4 years is 107%.

Back to Top